Diabetic Retinopathy News and Research

RSS
In the initial stages, people with diabetic retinopathy may not notice their vision changing. Diabetics sometimes experience rapid changes in blood sugar that can temporarily cause blurry vision even when retinopathy is not present. If a person notices a few specks or spots floating in his visual field, this may mean he has developed proliferative diabetic retinopathy, the growth of abnormal new blood vessels on the retina and optic nerve. High blood sugar levels have been linked in studies to retinal blood vessel abnormalities. Blurred vision may occur when the macula--the small area at the center of the retina--swells as it fills with fluid that has leaked from retinal blood vessels. Because damage to the eye often develops slowly, early detection of diabetes and control of blood sugar through diet and medications can make a crucial difference in saving vision.

Effective diabetic retinopathy treatments include laser photocoagulation for early to moderate stages and a microsurgery called vitrectomy for repair of eyes with extensive damage. Injectable and oral medications that act on abnormal blood vessels to control diabetic retinopathy before vision loss occurs are now in development. Early detection would be key to the effectiveness of these treatments, also.
Sun Pharma, Intrexon partner to develop controllable gene-based therapies for ocular diseases

Sun Pharma, Intrexon partner to develop controllable gene-based therapies for ocular diseases

New laser provides better treatment for eye diseases in diabetes patients

New laser provides better treatment for eye diseases in diabetes patients

ThromboGenics, Bicycle to develop and commercialize novel drugs for ophthalmic diseases

ThromboGenics, Bicycle to develop and commercialize novel drugs for ophthalmic diseases

Regeneron, Bayer report positive results from Phase 3 VIVID-DME and VISTA-DME trials of EYLEA for DME

Regeneron, Bayer report positive results from Phase 3 VIVID-DME and VISTA-DME trials of EYLEA for DME

University of Florida receives RPB Sanders Construction grant

University of Florida receives RPB Sanders Construction grant

Researchers discover new protein that encourages ‘bad’ blood vessel growth

Researchers discover new protein that encourages ‘bad’ blood vessel growth

'Sleep Mask' prototype: The world's first non-invasive treatment for sight loss

'Sleep Mask' prototype: The world's first non-invasive treatment for sight loss

New data suggest PaQ device can reduce known barriers to insulin therapy among people with type 2 diabetes

New data suggest PaQ device can reduce known barriers to insulin therapy among people with type 2 diabetes

Ico Therapeutics completes Phase 2 iDEAL study for treatment of diabetic macular edema

Ico Therapeutics completes Phase 2 iDEAL study for treatment of diabetic macular edema

Novel method introduced for detecting retinal micro-aneurysms that pose high risk for leakage

Novel method introduced for detecting retinal micro-aneurysms that pose high risk for leakage

Research on total anomalous pulmonary venous connection

Research on total anomalous pulmonary venous connection

New skin cancer drug successfully tested in humans

New skin cancer drug successfully tested in humans

Alimera announces availability of ILUVIEN in U.K. for chronic DME treatment

Alimera announces availability of ILUVIEN in U.K. for chronic DME treatment

Acucela begins phase 2b/3 clinical trial of emixustat hydrochloride to treat GA associated with dry AMD

Acucela begins phase 2b/3 clinical trial of emixustat hydrochloride to treat GA associated with dry AMD

Ceregene announces top-line data from CERE-12 Phase 2b clinical study for Parkinson's disease

Ceregene announces top-line data from CERE-12 Phase 2b clinical study for Parkinson's disease

Research shows diabetes trials worldwide failing to address key issues relating to condition

Research shows diabetes trials worldwide failing to address key issues relating to condition

Researchers work on stem cell treatments to halt vision loss caused by diabetic retinopathy

Researchers work on stem cell treatments to halt vision loss caused by diabetic retinopathy

Vision CRC develops retinal camera for detection of blinding eye disease and general health disorders

Vision CRC develops retinal camera for detection of blinding eye disease and general health disorders

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.